Stocks & Investing
Mon, September 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 31, 2024
[ 12:00 AM ] - WOPRAI
Thu, July 25, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 8, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 2, 2024
[ 12:00 AM ] - WOPRAI
Thu, April 25, 2024
[ 12:00 AM ] - WOPRAI
Fri, February 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, February 1, 2024
[ 12:00 AM ] - WOPRAI
Wed, December 20, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
Thu, November 2, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, October 31, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 2, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 23, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 2, 2023
[ 12:00 AM ] - WOPRAI
Wed, January 11, 2023
[ 12:00 AM ] - WOPRAI
Mon, December 19, 2022
[ 12:00 AM ] - WOPRAI
Wed, November 9, 2022
Thu, November 3, 2022
[ 12:00 AM ] - WOPRAI
Thu, October 20, 2022
[ 12:00 AM ] - WOPRAI
Fri, July 22, 2022
[ 12:00 AM ] - WOPRAI
Fri, June 24, 2022
[ 12:00 AM ] - WOPRAI
Fri, June 17, 2022
[ 12:00 AM ] - WOPRAI
Sat, January 22, 2022
[ 12:00 AM ] - WOPRAI
Tue, May 18, 2021
[ 12:00 AM ] - WOPRAI
Fri, May 14, 2021
[ 12:00 AM ] - WOPRAI
Mon, March 8, 2021 Robbie Marcus Maintained (ZBH) at Hold with Decreased Target to $120 on, Sep 16th, 2024
Robbie Marcus of JP Morgan, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Hold with Decreased Target from $125 to $120 on, Sep 16th, 2024.
Robbie has made no other calls on ZBH in the last 4 months.
There are 17 other peers that have a rating on ZBH. Out of the 17 peers that are also analyzing ZBH, 10 agree with Robbie's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Richard Newitter of "Truist Securities" Reiterated at Hold with Decreased Target to $112 on, Friday, September 13th, 2024
- Mike Polark of "Wolfe Research" Initiated at Hold on, Tuesday, September 10th, 2024
- William Plovanic of "Canaccord Genuity" Maintained at Hold with Decreased Target to $115 on, Tuesday, September 10th, 2024
- Joshua Jennings of "TD Cowen" Maintained at Hold with Decreased Target to $119 on, Friday, September 6th, 2024
- Vijay Kumar of "Evercore ISI Group" Maintained at Hold and Held Target at $113 on, Thursday, September 5th, 2024
- Mike Matson of "Needham" Reiterated at Hold on, Thursday, August 8th, 2024
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Decreased Target to $120 on, Monday, July 15th, 2024
- Joanne Wuensch of "Citigroup" Maintained at Hold with Decreased Target to $120 on, Wednesday, July 10th, 2024
- Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $115 on, Monday, July 1st, 2024
- David Roman of "Goldman Sachs" Initiated at Hold and Held Target at $129 on, Thursday, May 30th, 2024
These are the ratings of the 7 analyists that currently disagree with Robbie
- Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $130 on, Thursday, August 8th, 2024
- Steven Lichtman of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Thursday, August 8th, 2024
- Danielle Antalffy of "UBS" Maintained at Strong Sell with Decreased Target to $107 on, Thursday, August 8th, 2024
- Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $128 on, Thursday, August 8th, 2024
- Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $145 on, Thursday, August 8th, 2024
- Matt Miksic of "Barclays" Maintained at Sell with Decreased Target to $125 on, Friday, May 31st, 2024
- David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $150 on, Tuesday, May 21st, 2024
